News | Stents Bifurcation | March 31, 2017

Tryton Medical Announces First U.S. Commercial Case with Tryton Side Branch Stent

Patient with coronary bifurcation lesion involving large side branch treated with first dedicated bifurcation stent to receive regulatory approval in the U.S.

Tryton Medical, Side Branch Stent, first U.S. commercial case, New York-Presbyterian Hospital, Columbia University Medical Center

March 31, 2017 — Tryton Medical Inc. recently announced that the first U.S. commercial case using the Tryton Side Branch Stent was completed at New York-Presbyterian Hospital/Columbia University Medical Center in New York City. The device was used to treat a coronary bifurcation lesion involving a large side branch (appropriate for a ≥2.5mm stent) in a procedure performed by Martin Leon, M.D., director of the Center for Interventional Vascular Therapy, and Ajay Kirtane, M.D., SM, director of the Cardiac Catheterization Laboratory.

Watch a VIDEO demonstration of the deplyment for the Tryton Dedicated Bifurcation Stent.

pproximately 20-30 percent of all patients undergoing percutaneous coronary interventions (PCI) to open blocked arteries have a bifurcation lesion. The Tryton Side Branch Stent recently became the first dedicated bifurcation stent to receive regulatory approval in the United States. Tryton has signed a strategic distribution agreement with Cardinal Health enabling Cordis, its interventional vascular business, to be the exclusive distributor of the Tryton Side Branch Stent in the U.S.

The Tryton Side Branch Stent System is built using proprietary Tri-Zone technology to offer a dedicated strategy for treating bifurcation lesions. Tryton’s cobalt chromium stent is deployed in the side branch artery using a standard single wire balloon-expandable stent delivery system. A conventional drug-eluting stent is then placed in the main vessel.

Read the article "FDA Clears First Dedicated Coronary Bifurcation Stent."

For more information: www.trytonmedical.com


Related Content

News | Stents Bifurcation

September 21, 2022 — Medtronic announced today that it has received Food and Drug Administration (FDA) approval for the ...

Home September 21, 2022
Home
News | Stents Bifurcation

May 29, 2018 – Medtronic plc announced the initiation of a U.S. clinical study to assess the safety and efficacy of drug ...

Home May 29, 2018
Home
News | Stents Bifurcation

January 18, 2018 – West Hills Hospital & Medical Center, a full-service acute care facility, announces the first ...

Home January 18, 2018
Home
Videos | Stents Bifurcation

Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at ...

Home November 15, 2017
Home
News | Stents Bifurcation

November 1, 2017 — The double kissing (DK) crush two-stent technique was associated with a lower rate of target lesion ...

Home November 01, 2017
Home
News | Stents Bifurcation

September 21, 2017 — Cardinal Health and Tryton Medical Inc. announced that the Tryton coronary Side Branch Stent was ...

Home September 21, 2017
Home
Videos | Stents Bifurcation

This video, provided by Tryton, demonstrates the implantation of the Tryton Side Branch Stent. It became the first ...

Home March 06, 2017
Home
Technology | Stents Bifurcation

March 6, 2017 – The U.S. Food and Drug Administration (FDA) has granted pre-market approval (PMA) for the Tryton Side ...

Home March 06, 2017
Home
News | Stents Bifurcation

October 28, 2016 – Tryton Medical Inc., a primary developer of stents to treat coronary bifurcation lesions, and ...

Home October 28, 2016
Home
News | Stents Bifurcation

October 14, 2015 — Tryton Medical Inc. announced results from the pivotal Tryton Confirmatory Study confirming the ...

Home October 14, 2015
Home
Subscribe Now